TELA TELA Bio Corp Profit After Tax

Corporate emblem and logo of TELA Bio, Inc. (TELA)

The integration of OviTex biomatrices into hospital protocols creates a high level of customer dependency on TELA Bio, Inc. (TELA). Total company profit on the GURU.Markets chart confirms this trend, where the parameter value equals -0.04. Implant patents and insurance barriers hinder the expansion of new players. Meanwhile, the active growth in sales of biosynthetic meshes for hernia repair is currently effectively increasing the issuer's aggregate revenue.

Net Income: TELA Bio (TELA) for 07/04/2022 - 10/31/2026

Financial and market metric breakdowns for telabio.com (TELA)

- market value and analyst target forecast:
Stock Price TELA Bio|TELA - Price Target Chart
- market capitalization data:
Market Valuation TELA Bio, Inc.|TELA - Enterprise Value
- issuer book value statistics:
Net Asset Value per Share TELA Bio|TELA - Company Net Assets|Market Capitalization to Book Value Ratio telabio.com|TELA - Cumulative Company Assets
- debt burden and liquidity indicators:
Aggregate Debt to Capital TELA Bio, Inc.|TELA - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient TELA Bio|TELA - Company Aggregate Debts|Debt to Book Value TELA Bio, Inc.|TELA - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings TELA Bio|Quick Liquidity Indicator telabio.com
- company profitability and valuation multiples indicators:
TELA - Net Profit
Fundamental valuation:TELA, TELA Bio Corp
Flagship merchandise of TELA Bio Corp

Amid intense pricing competition with medical behemoths and a dependence on surgeon preferences, the final financial result of TELA Bio, Inc. (TELA) demonstrates the business's actual ability to generate cash flow. This indicator captures net income minus all operating expenses and taxes, allowing investors to assess capital management efficiency and the asset's fundamental resilience to market downturns.

Key competitors

Dexcom CGM (DXCM) - Net Profit|Company Net Income Penumbra, Inc.|novanta.com - Profit After Tax|Net Profit HAE|INSP - Company Net Income|PROCEPT BioRobotics Inc - Net Income|Net Profit CONMED Inc. CNMD|PLSE: Net Income|inmodemd.com - Profit After Payment of Taxes|PMI: Net Profit|SRDX - Net Financial Result|SENS (Senseonics Holdings) - Net Profit|Net Income NeuroPace Medical (NPCE)|Net Income TCMD (Tactile Systems Technology)|SNWV (sanuwave.com) - Final Profit|Company Net Income Outset Medical OM|ELMD - Net Income|LENSAR, Inc - Net Profit|Company Net Income AVITA Medical Inc|PROF: Net Profit|Company Profit BDMD|EDAP (EDAP TMS SA) - Net Profit|Bovie Medical (APYX) - Net Financial Result|Net Profit ICCM|Net Income pulmonx.com LUNG|Net Profit CTSO (CytoSorbents Corporation)|Net Profit sensushealthcare.com SRTS|ZYXI - Company Net Income|ECOR: Company Net Income|RBOT (vicarioussurgical.com) - Net Income|Inspira Technologies - Final Profit|ICU (SeaStar Medical Holding) - Net Profit|Company Net Income IRIDEX Corp. IRIX|Company Net Income Intelligent Bio Solutions (INBS)|beyondair.net (XAIR) - Annual Net Income|Profusa, Inc. - Net Income|Net Profit STRATA Skin Sciences Inc. SSKN|GlucoTrack - Net Profit|Net Financial Result NanoVibronix Inc. NAOV|Venus Concept (VERO) - Company Net Income|Profit After Tax NUWE (Nuwellis Inc)|Company Net Income Aethlon|Net Income TransEnterix (ASXC)|Net Profit AVGR|BSGM - Company Net Income|Company Net Income Cutera CUTR|KNW: Company Profit|NARI: Net Income|Nevro Medical - Profit After Payment of Taxes|RSLS (reshapelifesciences.com) - Net Income|SILK: Profit After Payment of Taxes